UnitedHealth stock is trading -8.18% below its average target price of $592.09 after dropping -1.1% during today's evening session. Analysts are giving the large-cap Medical Specialities company an average rating of buy and target prices ranging from $500.0 to $660.0 per share.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.6%. The stock's short ratio is 2.41. The company's insiders own 0.25% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 89.4%. In conclusion, we believe there is mixed market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-09-30 | Vanguard Group Inc | 9% | 83,610,224 | $45,457,205,971 |
2023-09-30 | Blackrock Inc. | 8% | 72,926,715 | $39,648,795,877 |
2023-09-30 | State Street Corporation | 5% | 44,427,484 | $24,154,334,175 |
2023-09-30 | FMR, LLC | 5% | 43,494,303 | $23,646,982,336 |
2023-09-30 | Capital World Investors | 3% | 28,853,252 | $15,686,935,836 |
2023-09-30 | Price (T.Rowe) Associates Inc | 3% | 26,758,148 | $14,547,869,708 |
2023-09-30 | Wellington Management Group, LLP | 3% | 25,220,234 | $13,711,736,636 |
2023-09-30 | JP Morgan Chase & Company | 3% | 23,323,618 | $12,680,584,463 |
2023-09-30 | Geode Capital Management, LLC | 2% | 17,869,985 | $9,715,553,313 |
2023-09-30 | Morgan Stanley | 2% | 15,716,887 | $8,544,957,009 |